The epipodophyllotoxin derivatives VM26 and VP16: experimental and clinical aspects.
Dombernowsky
P
P
Hansen
H H
HH
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005047:Etoposide / Q000627:therapeutic use*; D006801:Humans; D011034:Podophyllotoxin / Q000031:analogs & derivatives*; D013713:Teniposide / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D005047:Etoposide; D013713:Teniposide; D011034:Podophyllotoxin